DDMODEL00000008: Rocchetti_2013_oncology_TGI_combo

Short description:
PKPD model of tumor growth after administration of an anti-angiogenic agent, bevacizumab, as single-agent and combination therapy in tumor xenografts
PharmML 0.8.x (0.8.1) |
|
|
|
Paolo Magni
|
Context of model development: | Combination Therapy Dose Selection; Candidate Comparison, Selection, Human Dose Prediction; |
Model compliance with original publication: | Yes; |
Model implementation requiring submitter’s additional knowledge: | No; |
Modelling context description: | PURPOSE: Pharmacokinetic-pharmacodynamic (PK-PD) models able to predict the action of anticancer compounds in tumor xenografts have an important impact on drug development. In case of anti-angiogenic compounds, many of the available models show difficulties in their applications, as they are based on a cell kill hypothesis, while these drugs act on the tumor vascularization, without a direct tumor cell kill effect. For this reason, a PK-PD model able to describe the tumor growth modulation following treatment with a cytostatic therapy, as opposed to a cytotoxic treatment, is proposed here. METHODS: Untreated tumor growth was described using an exponential growth phase followed by a linear one. The effect of anti-angiogenic compounds was implemented using an inhibitory effect on the growth function. The model was tested on a number of experiments in tumor-bearing mice given the anti-angiogenic drug bevacizumab either alone or in combination with another investigational compound. Nonlinear regression techniques were used for estimating the model parameters. RESULTS: The model successfully captured the tumor growth data following different bevacizumab dosing regimens, allowing to estimate experiment-independent parameters. A combination model was also developed under a 'no-interaction' assumption to assess the effect of the combination of bevacizumab with a target-oriented agent. The observation of a significant difference between model-predicted and observed tumor growth curves was suggestive of the presence of a pharmacological interaction that was further accommodated into the model. CONCLUSIONS: This approach can be used for optimizing the design of preclinical experiments. With all the inherent limitations, the estimated experiment-independent model parameters can be used to provide useful indications for the single-agent and combination regimens to be explored in the subsequent development phases.; |
Modelling task in scope: | estimation; |
Nature of research: | Preclinical development; In vivo; |
Therapeutic/disease area: | Oncology; |
Annotations are correct. |
|
This model is not certified. |
- Additional Files
- Executable_Rocchetti_2013_oncology_TGI_combo_model.txt
- Simulated_rocchetti2013_data.csv
- Executable_Rocchetti_2013_oncology_TGI_combo.ctl
- Executable_Rocchetti_2013_oncology_TGI_combo_project.mlxtran
- DDMODEL00000008.rdf
- Command.txt
- Executable_Rocchetti_2013_oncology_TGI_combo.mdl
- Output_simulated_Rocchetti.pdf
- Model_Accomodations.txt
- Model owner: Paolo Magni
- Submitted: Sep 26, 2014 11:18:04 AM
- Last Modified: Oct 10, 2016 7:53:05 PM
Revisions
-
Version: 6
- Submitted on: Oct 10, 2016 7:53:05 PM
- Submitted by: Paolo Magni
- With comment: Edited model metadata online.
-
Version: 4
- Submitted on: May 24, 2016 11:17:40 PM
- Submitted by: Paolo Magni
- With comment: Updated model annotations.
-
Version: 3
- Submitted on: Dec 10, 2015 10:37:36 PM
- Submitted by: Paolo Magni
- With comment: Edited model metadata online.
-
Version: 1
- Submitted on: Sep 26, 2014 11:18:04 AM
- Submitted by: Paolo Magni
- With comment: Import of Rocchetti_2013_oncology_TGI_antiangiogenic_combo
Name
Generated from MDL. MOG ID: rocchetti2013
Independent Variables
|
Function Definitions
|
Parameter Model:
Random Variables
Population Parameters
Individual Parameters
Structural Model:
Variables
Observation Model:
Continuous Observation
External Dataset
OID
|
|
Tool Format
|
NONMEM
|
File Specification
Format
|
|
Delimiter
|
comma
|
File Location
|
Simulated_rocchetti2013_data.csv
|
Column Definitions
Column ID | Position | Column Type | Value Type |
---|---|---|---|
Column Mappings
Column Ref | Modelling Mapping |
---|---|
Estimation Step
OID
|
|
Dataset Reference
|
Parameters To Estimate
Parameter | Initial Value | Fixed? | Limits |
---|---|---|---|
pm.POP_LAMBDA0 |
true
|
||
pm.POP_LAMBDA1 |
true
|
||
pm.POP_W0 |
true
|
||
pm.POP_K1 |
true
|
||
pm.POP_K2 |
true
|
||
pm.POP_IC50 |
true
|
||
pm.POP_IC50COMBO |
false
|
||
pm.POP_KA_A |
true
|
||
pm.POP_KE_A |
true
|
||
pm.POP_FV1_A |
true
|
||
pm.POP_KA_B |
true
|
||
pm.POP_KE_B |
true
|
||
pm.POP_K21 |
true
|
||
pm.POP_K12 |
true
|
||
pm.POP_FV1_B |
true
|
||
pm.POP_EMAX |
true
|
||
pm.CV |
false
|
Operations
Operation:
Op Type
|
generic
|
Operation Properties
Name | Value |
---|---|
algo
|
Step Dependencies
Step OID | Preceding Steps |
---|---|